Literature DB >> 17631270

Peptide rescues GLUT4 recruitment, but not GLUT4 activation, in insulin resistance.

Makoto Funaki1, Kate Benincasa, Paramjeet K Randhawa.   

Abstract

Insulin-stimulated GLUT4 recruitment to the plasma membrane is impaired in insulin resistance. We recently reported that a cell permeable phosphoinositide-binding peptide induces GLUT4 recruitment as potently as insulin, but does not activate GLUT4 to initiate glucose uptake. Here we investigated whether the peptide-induced GLUT4 recruitment is intact in insulin resistance. The expression levels of GLUT1 and GLUT4 were unaffected by chronically treating 3T3-L1 adipocytes with insulin. GLUT4 recruitment by acute insulin stimulation after chronic insulin treatment was significantly reduced, but was fully restored by the peptide treatment. However, subsequent acute insulin stimulation to activate GLUT4 failed to increase glucose uptake in peptide-pretreated cells. Insulin-stimulated GLUT1 recruitment was unaffected by the peptide pretreatment. These results suggest that the GLUT4 recruitment signal caused by the peptide is intact in insulin resistance, but GLUT4 activation that occurs subsequent to recruitment is not rescued by the peptide treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631270     DOI: 10.1016/j.bbrc.2007.06.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.

Authors:  Yiling Si; Yali Zhao; Haojie Hao; Jiejie Liu; Yelei Guo; Yiming Mu; Jing Shen; Yu Cheng; Xiaobing Fu; Weidong Han
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

2.  Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle.

Authors:  Lykke Sylow; Thomas E Jensen; Maximilian Kleinert; Kurt Højlund; Bente Kiens; Jørgen Wojtaszewski; Clara Prats; Peter Schjerling; Erik A Richter
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.